Marathon Asset Management (UK)’s Mead Johnson Nutrition Company MJN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-993,274
Closed -$88.9M 104
2017
Q1
$88.9M Buy
993,274
+319,043
+47% +$26.2M 1.95% 15
2016
Q4
$48M Buy
674,231
+56,928
+9% +$4.24M 1.04% 36
2016
Q3
$49M Buy
617,303
+97,221
+19% +$8.29M 1.05% 34
2016
Q2
$47.4M Buy
520,082
+9,906
+2% +$839K 1.01% 34
2016
Q1
$43.5M Buy
510,176
+83,487
+20% +$6.21M 0.96% 38
2015
Q4
$33.8M Buy
+426,689
New +$33.6M 0.77% 53

Other funds holding MJN

Marathon Asset Management (UK)'s MJN Position: Q2 2017 in Review

Marathon Asset Management (UK) sold out of Mead Johnson Nutrition Company (MJN) in Q2 2017, closing a stake of 993,274 shares — an estimated $88.9M sold.

Marathon Asset Management (UK) first reported a position in MJN in Q4 2015 and held it in 6 quarters. The position peaked at $88.9M in Q1 2017. 7 funds tracked by Wall St. Rank hold MJN as of Q2 2017.

  • Marathon Asset Management (UK) reported no remaining Mead Johnson Nutrition Company position as of Q2 2017 after selling out during the quarter.
  • Marathon Asset Management (UK) sold 993,274 Mead Johnson Nutrition Company shares in Q2 2017, an estimated $88.9M.
  • Marathon Asset Management (UK) first reported a position in Mead Johnson Nutrition Company in Q4 2015 and held it in 6 quarters.
  • Marathon Asset Management (UK)'s Mead Johnson Nutrition Company position peaked at $88.9M in Q1 2017.
  • 7 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q2 2017.

Based on Marathon Asset Management (UK)'s 13F filing for Q2 2017, filed 18 Jul 2017.